Contrast Enhanced Ultrasound Market Overview
According to fortune business insights, the contrast enhanced ultrasound market size was valued at USD 2.19 billion in 2025 and is expected to grow from USD 2.32 billion in 2026 to USD 3.63 billion by 2034, exhibiting a CAGR of 5.79% during the forecast period.
The market is growing as standardized guidance on the use of contrast-enhanced ultrasound (CEUS), particularly for liver imaging, increases clinician confidence and adoption. This encourages hospitals and imaging centers to invest in training and routine use, expanding exam volumes and driving the consumption of contrast agents.
Major Players Profiled in the Market Report:
Latest Trends
AI and Automation to Improve Reproducibility and Quantification
The integration of Artificial Intelligence (AI) and automation is a significant trend. AI-driven image optimization and automated measurements reduce user dependency and improve the consistency and reproducibility of CEUS exams. This makes the technology more accessible and favorable for community hospitals and smaller imaging centers. For instance, in February 2025, Koninklijke Philips N.V. introduced CEUS-focused features like “CEUS AutoScan” and other AI workflow enhancements.
Drivers & Restraints
Expanding Access and Utilization Through Reimbursement Boosts the Market Growth
Increased reimbursement for CEUS procedures is a major market driver. Favorable payment policies, such as the doubling of Medicare’s outpatient payment for non-cardiac CEUS in January 2026, directly incentivize providers to schedule more CEUS exams and invest in contrast-capable equipment, supporting overall market expansion.